Cumbo Alexander
President and CEO
Cumbo Alexander has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Cumbo Alexander is listed as President and CEO at Solid Biosciences Inc. Inside the rolling window, Cumbo Alexander reported no open-market purchases and 4 open-market sales totaling $984K in SLDB. The largest disclosed transaction in the window is a sale of 80,258 SLDB shares on Feb 2, 2026, worth $517K.
Companies traded
Other insiders at SLDB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$984K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cumbo Alexander made?
Cumbo Alexander has filed 4 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Cumbo Alexander trade?
Cumbo Alexander has filed SEC Form 4 disclosures for 1 company, including SLDB.
When was Cumbo Alexander's most recent SEC Form 4 filing?
Cumbo Alexander's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Cumbo Alexander's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cumbo Alexander is listed as President and CEO.
What is Cumbo Alexander's total buy and sell value in the current window?
Inside the rolling retention window, Cumbo Alexander bought $0 and sold $984K based on SEC Form 4 filings.
What was Cumbo Alexander's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 80,258 SLDB shares on 2026-02-02, worth $517K, per SEC Form 4 filings.